Addenbrooke's cognitive examination III in the diagnosis of dementia: a critical review

D Bruno, S Schurmann Vignaga - Neuropsychiatric Disease and …, 2019 - Taylor & Francis
Addenbrooke's cognitive examination III is a screening test that is composed of tests of
attention, orientation, memory, language, visual perceptual and visuospatial skills. It is useful …

Neuropsychological measures in the Arab world: A systematic review

AF Fasfous, HF Al-Joudi, AE Puente… - Neuropsychology …, 2017 - Springer
Although Arabic is one of the most widely used languages in the world, little is known on the
availability of standardized neuropsychological tests in Arabic. We review the literature …

Addenbrooke's cognitive examination III: psychometric characteristics and relations to functional ability in dementia

M So, D Foxe, F Kumfor, C Murray, S Hsieh… - Journal of the …, 2018 - cambridge.org
Objectives: The Addenbrooke's Cognitive Examination (ACE) is a common cognitive
screening test for dementia. Here, we examined the relationship between the most recent …

Clinical predictors to cognitive impairment in multiple sclerosis patients

H Elshebawy, EM Fahmy, NM Elfayoumy… - The Egyptian Journal of …, 2021 - Springer
Background Cognitive dysfunction is increasingly recognized in multiple sclerosis, even in
the early phase of the disease. Multiple sclerosis patients with even mild cognitive deficits …

Cognitive impairment in health care workers recovering from COVID-19 infection: a cross-sectional comparative study

AKAE Omar, SMA Dahesh, DES Ellakwa… - Middle East Current …, 2022 - Springer
Background The COVID-19 outbreak has infected people all over the world where many
clinics are being constructed to diagnose and treat lingering symptoms or long COVID …

[HTML][HTML] Validation of the Portuguese version of Addenbrooke's Cognitive Examination III in mild cognitive impairment and dementia

B Peixoto, M Machado, P Rocha… - … in Clinical and …, 2018 - advances.umw.edu.pl
Background. Cognitive assessment is central to the diagnosis of cognitive impairment and
dementia, and it should be performed in all patients in the early stages of the disease …

Relation of serum level of tumor necrosis factor-alpha to cognitive functions in patients with Parkinson's disease

MM El-Kattan, LA Rashed, SR Shazly… - The Egyptian Journal of …, 2022 - Springer
Background Inflammation is suggested to play a role in the development of non-motor
Parkinson's disease (PD) symptoms. We aimed to investigate the association between …

Late versus early onset depression in elderly patients: Vascular risk and cognitive impairment

AH Hashem, MA Gomaa, OO Khalaf - Current aging science, 2017 - ingentaconnect.com
Background: Three-quarters of patients with major depressive disorder have late-onset
depression. Late-onset depression is more often associated with cognitive impairment than …

Relation of serum levels of homocysteine, vitamin B12 and folate to cognitive functions in multiple sclerosis patients

EM Fahmy, NM Elfayoumy, AM Abdelalim… - International Journal …, 2018 - Taylor & Francis
Background: Hyperhomocysteinemia, vitamin B12 and folate deficiency have been linked to
cognitive dysfunction in multiple sclerosis (MS) patients. Objective: This study aimed to …

PSYCHOMETRIC AND NORMATIVE INDICATORS OF THE PORTUGUESE VERSION OF THE ADDENBROOKE'S COGNITIVE EXAMINATION-III. PRELIMINARY …

A Machado, É Baeta, P Pimentel… - Acta …, 2015 - search.ebscohost.com
Background: Recently a third version of the Addenbrooke's Cognitive Examination (ACE-III)
was developed in order to improve previous versions. The present work aims to determine …